Analytical Data
-
基因名
TMEFF1/Tomoregulin-1
- Application
-
别名
H7365 Transmembrane protein with EGF-like and one follistatin-like domain C9orf2
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8IYR6
-
表达区间
40-330aa
-
分子量
38.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TMEFF1, also known as Tomoregulin-1, is a protein encoded by the TMEFF1 gene, which is located on chromosome 3 in humans. Initially discovered in the context of prostate cancer, TMEFF1 is recognized for its role in cell signaling and proliferation. It is a type I membrane protein that exhibits potential tumor-suppressive properties, influencing processes such as cellular growth, differentiation, and apoptosis. The protein interacts with various signaling pathways, including the epidermal growth factor (EGF) receptor cascade, suggesting its involvement in tumor biology. Research has indicated that TMEFF1 expression is often downregulated in several cancer types, which underscores its potential as a biomarker and therapeutic target. Additionally, studies have shown that TMEFF1 may exhibit neuroprotective effects, indicating its broader relevance in tissue homeostasis and regenerative processes. Given its multifunctional roles, the recombinant expression of TMEFF1 is being explored for therapeutic applications, including cancer treatment and neurological disorders. The development of TMEFF1 as a recombinant protein is crucial for further understanding its biological functions and mechanisms, ultimately paving the way for novel clinical interventions. Overall, the ongoing research into TMEFF1/Tomoregulin-1 represents a significant stride in deciphering the intricate interactions of cellular signaling pathways and their implications in human health and disease.
